syringaldehyde has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TH; Fu, YS; Huang, L; Lai, D; Weng, CF; Weng, L; Weng, WH; Zheng, Q | 1 |
1 other study(ies) available for syringaldehyde and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Syringaldehyde promoting intestinal motility with suppressing α-amylase hinders starch digestion in diabetic mice.
Topics: alpha-Amylases; Animals; Benzaldehydes; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Gastrointestinal Motility; Glucose Tolerance Test; Jejunum; Male; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Muscarinic Agonists; Receptors, Muscarinic; Starch | 2021 |